A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorOutliers, Inc.
About this trial
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.
Eligibility criteria
Qualifiers
Aged 18-55 years
Currently prescribed stimulant medication for ADHD
Experiencing: sleep difficulty, irritability, anxiety, brain fog
Stable medication dose ≥3 months
Disqualifiers
Chronic conditions (e.g. cancer, mental illness)
Use of psychiatric medications besides stimulants
Pregnancy, breastfeeding, thyroid, liver, kidney conditions
Recent smokers or heavy alcohol use
Trial design
Treatments tested in this trial
- Stasis Daytime and Nighttime
- Placebo
Treatment groups
90 Participants
are divided into 2 treatment groupsSponsors and collaborators
Outliers, Inc.
Lead sponsor
Citruslabs
Collaborator
Source ClinicalTrials.gov